Characterization of a previously unrecognized clinical phenomenon: Delayed shock after cardiac implantable electronic device extraction

Heart Rhythm. 2017 Oct;14(10):1552-1558. doi: 10.1016/j.hrthm.2017.05.032. Epub 2017 May 26.

Abstract

Background: Transvenous lead extraction remains a challenging procedure with inherent risk and associated complications.

Objective: We sought to characterize and evaluate predictors of delayed shock after transvenous lead extraction with no intraprocedural complications.

Methods: We retrospectively analyzed data of 217 consecutive patients who underwent extraction between 2010 and 2015. The primary end point was sudden onset of shock more than 4 hours after the completion of the procedure. Shock was defined as at least 30 minutes of persistent hypotension, necessitating vasopressors. Patients with mechanical or hemorrhagic shock were excluded.

Results: Seventeen patients (9%) developed delayed shock during the first 24 hours. Reasons for shock were sepsis (47%) or no apparent cause (53%). In multivariate analysis, patients with delayed shock had significantly lower glomerular filtration rate (median estimated glomerular filtration rate 53 mL/min vs 73 mL/min; P = .001), had more signs of systemic infection before extraction (fever, bacteremia, and leukocytosis; P < .05), and had more lead/tip remnants (29% vs 3%; P < .001). Patients presenting with delayed shock had significantly higher mortality rates at 1-year follow-up (10 [59%] vs 40 [23%], respectively; P < .01). Multivariate analysis adjusted for 1-year mortality risk was 114% higher (hazard ratio 2.14; 95% confidence interval 1.02-4.47; P < .05) in patients presenting with delayed shock.

Conclusion: We describe a previously unrecognized clinical phenomenon of delayed shock developing after extraction. Patients with predictors of this condition at baseline should be identified and followed up closely. Even with prompt treatment, long-term mortality rates remain high.

Keywords: CIED infection; Mortality; Shock; Transvenous lead extraction.

MeSH terms

  • Aged
  • Defibrillators, Implantable / adverse effects*
  • Device Removal / adverse effects*
  • Device Removal / mortality
  • Female
  • Follow-Up Studies
  • Humans
  • Israel / epidemiology
  • Male
  • Pacemaker, Artificial / adverse effects*
  • Prosthesis Design
  • Prosthesis Failure
  • Prosthesis-Related Infections / mortality*
  • Retrospective Studies
  • Risk Assessment*
  • Risk Factors
  • Survival Rate / trends
  • Time Factors
  • Treatment Outcome